Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors

Abstract Outcomes of 2‐year survivours undergoing allo‐haematopoietic stem cell transplantation at Oslo University Hospital were retrospectively assessed with the objectives of identification of risk factors for late death as possible means for precautionary measures and interventions to improve lon...

Full description

Bibliographic Details
Main Authors: B. Linder Grønvold, Maryan Mohamed Ali, Tor Å Myklebust, Andrea Lenartova, Mats Remberger, Ingerid Weum Abrahamsen, Geir Erland Tjønnfjord, Anders Eivind Myhre, Yngvar Fløisand, Tobias Gedde‐Dahl
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:eJHaem
Subjects:
aGvHD
Allo‐HSCT
cGvHD
GvHD‐prophylaxis
long‐term follow‐up
Online Access:https://doi.org/10.1002/jha2.842

Internet

https://doi.org/10.1002/jha2.842

Similar Items